European Archives - Page 77 of 1301 - European Medical Journal

AI Model Shows Breakthrough in Non-Invasive Prostate Cancer Diagnosis

A groundbreaking AI model, trained on over 1.3 million MRI–pathology pairs, is redefining prostate cancer diagnosis. The MRI‑PTPCa system delivers near‑perfect accuracy in grading tumors, offering a safe, noninvasive alternative to biopsies while improving clinical decision‑making and patient outcomes.

GLP-1 RAs May Halve Risk of Peptic Ulcer in Type 2 Diabetes

Learn how GLP-1 RAs may cut peptic ulcer risk in diabetes patients by nearly half.

Omalizumab Shows Promise for Treating Chronic Urticaria in Children

Learn how omalizumab shows high response rates and low side effects in children with chronic spontaneous urticaria.

Sponsored content: ADC-IO combination in comorbid patients with advanced urothelial cancer

This promotional material is intended for healthcare professionals only and has been commissioned and funded by Astellas Pharma Ltd…

EMJ Oncology 13 [Supplement 4] 2025

Sponsored Content: This promotional material is intended for healthcare professionals only and has been commissioned and funded by Astellas Pharma Ltd…

Chronic Liver Disease Remains Major Health Burden

The team concluded that CLD remains a major health burden in Thailand, highlighting the need for strong prevention strategies, early diagnosis, and equitable access to effective therapies.

Mini-Camera and AI Accurately Predict Heart Attack Recurrence

AI and imaging mini-cameras now reliably predict future heart attack risk, paving the way for more targeted treatment.

High Ischaemic Deficit Signals Stroke Risk in Takayasu Arteritis

A prospective study highlights that Takayasu arteritis patients with high ischemic deficits on CT perfusion scans face a sharply elevated risk of strokes and other ischemic events.

Medical Cannabis Improves Sleep and Mood in Patients with Insomnia

Medical cannabis linked to better sleep, mood, and life quality in insomnia patients over 18 months, real-world study finds.

MSD strikes $10bn deal for Verona Pharma

MSD has agreed to acquire UK biopharma company Verona Pharma in a $10bn deal, strengthening its cardio-pulmonary care portfolio.